Preliminary experience with chemotherapy in advanced salivary gland neoplasms
- 1 January 1988
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 16 (3) , 197-202
- https://doi.org/10.1002/mpo.2950160309
Abstract
Eight patients with advanced incurable salivary gland carcinoma were treated with the combination of cyclophosphamide, doxorubicin, and cisplatin (CAP). There were three clinical complete responses and two excellent partial responses. One of the three nonresponders had symptomatic improvement without any response in the measurable disease sites. Side effects were acceptable. All patients had moderate nausea and some degree of vomiting, which were adequately controlled by antiemetics. These results are preliminary but when considered with other reported trials using the same combination suggest an active treatment program for advanced neoplasms of the salivary glands.Keywords
This publication has 8 references indexed in Scilit:
- Cyclophosphamide, adriamycin, and cisdiamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancerCancer, 1983
- Chemotherapy of advanced salivary gland neoplasmsCancer, 1982
- Chemotherapy for salivary gland cancerThe Laryngoscope, 1982
- Fast neutrons in the treatment of salivary gland tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Cisplatin Therapy for Adenoid Cystic CarcinomaJAMA Otolaryngology–Head & Neck Surgery, 1981
- Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid glandCancer, 1981
- Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin:A case report with a review of the literatureCancer, 1979
- Chemotherapy of malignant major salivary gland neoplasms.A 25-year review of M.D. Anderson hospital experienceCancer, 1977